QA: Albireo Pharma INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001322505_2019_Albireo_Pharma_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001322505, Albireo Pharma INC

  xvar xval
0 AssetsCurrent 167,650,000
1 IntangibleAssetsNetIncludingGoodwill 17,260,000
2 PropertyPlantAndEquipmentNet 187,000
3 remainder_Assets 369,000
4 LiabilitiesCurrent 12,825,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 50,004,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,741,810
9 ResearchAndDevelopmentExpense 36,352,914
10 remainder_Expenses -3,436,500
11 remainder_Revenues 35,710
12 remainder_NetIncome -4,816,742
13 remainder_ComprehensiveNetIncome -493,662
  yvar yval
0 Assets 185,466,000
1 Liabilities 62,829,000
2 Expenses 50,658,224
3 Revenues 35,710
4 StockholdersEquity 122,637,000
5 NetIncome -55,439,256
6 ComprehensiveNetIncome -55,686,087
7 BaseVar 152,149,669
8 EconomicCapitalRatiobeforeLimitedLiability 1.70
9 EconomicCapitalRatio 2.82

Edgar->Model Mapping

Feature Distribution

Change over Time